Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder-Reference-Cited by-同舟云学术

Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder

Published:2019-06-29 Issue:13 Volume:44 Page:2268-2276
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol.

Author:

Thase Michael E.,Stanford Arielle D.,Memisoglu Asli,Martin William^ORCID,Claxton Amy,Bodkin J. Alexander,Trivedi Madhukar H.^ORCID,Fava Maurizio,Yu Miao,Pathak Sanjeev

Funder

Alkermes, Inc.

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/s41386-019-0451-3.pdf

Reference51 articles.

1. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10:e1001547.

2. Baldessarini RJ, Forte A, Selle V, Sim K, Tondo L, Undurraga J, et al. Morbidity in depressive disorders. Psychother Psychosom. 2017;86:65–72.

3. Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012;21:169–84.

4. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–17.

5. Ishak WW, Greenberg JM, Cohen RM. Predicting relapse in major depressive disorder using patient-reported outcomes of depressive symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression (IBI-D). J Affect Disord. 2013;151:59–65.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of buprenorphine for the treatment of depression: A systematic review and meta-analysis;Journal of Psychiatric Research;2023-05

2. Delta Opioid Receptor-Mediated Antidepressant-Like Effects of Diprenorphine in Mice;Journal of Pharmacology and Experimental Therapeutics;2022-12-01

3. Pharmacological Strategies for Suicide Prevention Based on the Social Pain Model: A Scoping Review;Psych;2022-08-05

4. Investigational Drugs for the Treatment of Depression (Part 2): Glutamatergic, Cholinergic, Sestrin Modulators, and Other Agents;Frontiers in Pharmacology;2022-06-17

5. Investigational Drugs for the Treatment of Depression (Part 1): Monoaminergic, Orexinergic, GABA-Ergic, and Anti-Inflammatory Agents;Frontiers in Pharmacology;2022-06-14